9月4日，2026年亚洲营养保健食品展（Vitafoods Asia）在泰国曼谷诗丽吉王后国家会议中心落下帷幕落幕。本届展会汇聚来自80多个国家和地区的800余家参展商。在首次设立的澳大利亚国家馆内，澳洲婴童营养品牌Witsbb健敏思与澳大利亚药品保健品协会（Complementary Medicines Australia, CMA）一同参展，澳大利亚驻泰大使Pablo Kang（巴勃罗·康）亲临Witsbb健敏思展位参观交流，“无敏原100+”成Witsbb健敏思与各专业采购商、行业分析师及同行从业者关注交流的高频词汇。
展会现场，Witsbb健敏思携“无敏原100+“核心系列产品——钙铁锌、维生素、DHA等悉数亮相，其过敏原筛查覆盖澳、中、美等12国及地区强制标注过敏原标准。据默多克儿童研究所2025年报告，澳洲约820万人过敏（占近1/3），而Witsbb健敏思2025年4月，发布了行业首份“无敏原100+透明清单”，首次系统性公开其产品排除的100多种常见食物过敏原；2026年2月，牵头并推动《无常见过敏原营养配方食品技术要求》团标发布，填补了相关细分领域的规范空白。
在澳大利亚本土市场，这一“无敏”理念同样经受住了严苛考验。在拥有34年历史的知名保健品零售连锁Mr Vitamins中，Witsbb健敏思维生素AD、D3、藻油DHA等多款产品持续热销，在婴童营养品核心区域并保持常态化补货。自2019年入华，Witsbb健敏思已连续多年亮相中国国际进口博览会、中国国际消费品博览会等，此次携手CMA参展Vitafoods Asia 2026，更是Witsbb健敏思深耕亚太市场、加速全球化布局的关键一步。
2026年亚洲营养保健食品展现场，Witsbb健敏思不止于展示——品牌正以母婴营养品的姿态深度参与，与来自亚洲及全球的行业伙伴展开交流对话，了解不同国家和地区对过敏家庭营养需求的差异化认知与应对实践。从澳大利亚到中国，从曼谷到全球，Witsbb健敏思正以开放的姿态融入更广阔的市场语境，倾听更多敏宝家庭的真实声音，让“无敏原100+，敏感宝宝放心吃”的承诺，跨越国界，走向更多需要它的地方。
Witsbb Joined CMA at Vitafoods Asia 2026, “100+ Allergen-Free” Becomes a Buzzword
On September 4, the 2026 Vitafoods Asia concluded at the Queen Sirikit National Convention Center in Bangkok, Thailand. The event brought together over 800 exhibitors from more than 80 countries and regions. For the first time, an Australian National Pavilion was established, where Australian children’s nutrition brand Witsbb exhibited alongside the Complementary Medicines Australia (CMA). The Australian Ambassador to Thailand, Pablo Kang, visited the Witsbb booth, where “100+ Allergen-Free” became a frequently discussed topic among professional buyers, industry analysts, and peers.
At the exhibition, Witsbb showcased its core “100+ Allergen-Free” product series – including Calcium‑Iron‑Zinc, Vitamins, DHA, and others. All products undergo allergen screening that meets the mandatory labeling requirements of 12 countries and regions, including Australia, China, and the United States.
According to a 2025 report by the Murdoch Children’s Research Institute, approximately 8.2 million people in Australia suffer from allergic diseases, accounting for nearly one‑third of the population. In response, Witsbb released the industry’s first “100+ Allergen-Free Transparent List” in April 2025, systematically disclosing over 100 common food allergens excluded from its products. In February 2026, Witsbb led the release of the group standard Technical Requirements for Common Allergen‑Free Nutritional Formula Foods, filling a regulatory gap in this niche sector.
In the Australian domestic market, this “allergen‑free” philosophy has also withstood rigorous scrutiny. At Mr Vitamins, a well‑known health product retail chain with 34 years of history, Witsbb’s Vitamin AD, Vitamin D3, and Algal Oil DHA have consistently enjoyed strong sales, maintaining regular restocking in the core children’s nutrition section. Since entering China in 2019, Witsbb has been featured multiple times at events such as the China International Import Expo and the China International Consumer Products Expo. This joint participation with CMA at Vitafoods Asia 2026 represents a pivotal step for Witsbb in deepening its presence in the Asia‑Pacific market and accelerating its global expansion.
Beyond product display, Witsbb engaged deeply with industry partners from Asia and beyond, exchanging insights on the diverse nutritional needs of allergy‑affected families in different regions. From Australia to China, and from Bangkok to the world, Witsbb is embracing a broader market context, listening to the real voices of families with sensitive children, and fulfilling its promise: “100+ Allergen-Free – safe for sensitive babies.” This commitment transcends borders, reaching more families in need.
You can also read about: How Osteopathic Treatment Can Help You Return to Sport Faster After an Injury